|
Name |
Oleic acid, 3-(octadecyloxy)propyl ester
|
Molecular Formula | C39H76O3 | |
IUPAC Name* |
3-octadecoxypropyl (Z)-octadec-9-enoate
|
|
SMILES |
CCCCCCCCCCCCCCCCCCOCCCOC(=O)CCCCCCC/C=C\CCCCCCCC
|
|
InChI |
InChI=1S/C39H76O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-36-41-37-34-38-42-39(40)35-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h18,20H,3-17,19,21-38H2,1-2H3/b20-18-
|
|
InChIKey |
DGJSXVYZCNEXGC-ZZEZOPTASA-N
|
|
Synonyms |
17367-41-8; Oleic acid 3-(octadecyloxy)propyl ester; 3-octadecoxypropyl (Z)-octadec-9-enoate; (Z)-9-Octadecenoic acid 3-(octadecyloxy)propyl ester; Oleic acid, 3-(octadecyloxy)propyl ester; 3-(Octadecyloxy)propyl (9E)-9-octadecenoate #
|
|
CAS | NA | |
PubChem CID | 21159937 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 593.0 | ALogp: | 16.6 |
HBD: | 0 | HBA: | 3 |
Rotatable Bonds: | 37 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 35.5 | Aromatic Rings: | 0 |
Heavy Atoms: | 42 | QED Weighted: | 0.033 |
Caco-2 Permeability: | -5.274 | MDCK Permeability: | 0.00000496 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.277 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 103.39% |
Volume Distribution (VD): | 4.089 | Fu: | 0.43% |
CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.119 |
CYP2C19-inhibitor: | 0.09 | CYP2C19-substrate: | 0.041 |
CYP2C9-inhibitor: | 0.02 | CYP2C9-substrate: | 0.929 |
CYP2D6-inhibitor: | 0.052 | CYP2D6-substrate: | 0.011 |
CYP3A4-inhibitor: | 0.18 | CYP3A4-substrate: | 0.011 |
Clearance (CL): | 4.556 | Half-life (T1/2): | 0.053 |
hERG Blockers: | 0.959 | Human Hepatotoxicity (H-HT): | 0.008 |
Drug-inuced Liver Injury (DILI): | 0.058 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.014 | Maximum Recommended Daily Dose: | 0.017 |
Skin Sensitization: | 0.989 | Carcinogencity: | 0.023 |
Eye Corrosion: | 0.542 | Eye Irritation: | 0.898 |
Respiratory Toxicity: | 0.723 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001842 | 0.905 | D00AOJ | 0.484 | ||||
ENC001705 | 0.766 | D0O1PH | 0.400 | ||||
ENC000741 | 0.677 | D0Z1QC | 0.395 | ||||
ENC000443 | 0.648 | D01NTX | 0.382 | ||||
ENC000437 | 0.646 | D00STJ | 0.378 | ||||
ENC000381 | 0.644 | D00FGR | 0.366 | ||||
ENC000576 | 0.640 | D07ILQ | 0.356 | ||||
ENC000436 | 0.638 | D05ZPL | 0.324 | ||||
ENC000438 | 0.638 | D00MLW | 0.318 | ||||
ENC000435 | 0.627 | D0Z5SM | 0.311 |